We are a clinical stage biopharmaceutical company dedicated

to develop drugs for neurological disorders

  • Yann GODFRIN, Ph.D.

    Chief Executive Officer

    15+ years of experience in management of biopharmaceutical companies focused product development. Co-founder, former CEO and CSO of ERYTECH Pharma, former CEO of Hemoxymed Europe, Dr Godfrin is an expert in pre-clinical and clinical product development strategy and has been consultant for several biotech companies. He is the inventor of more than 15 patents families and several scientific publications. Dr Godfrin holds a Ph.D. degree in Health & Life Sciences from the University of Nantes, an Engineer degree in Biomedical Sciences from the University of Compiegne and a Master degree in Pharmaceutical Drug Development from the University of Lyon.

  • Manuel BLANC, Ph.D.

    Chief Scientific Officer

    10+ years of experience in Preclinical Project Management, Strategy & Business Development in the biotech – pharma – healthcare industry. At NEURONAX, before its position as Chief Scientific Officer Dr. BLANC was Head of Preclinical Operations & Strategic Alliances. Prior to joining NEURONAX, he served as Business Development & Licensing Project Leader for ERYTECH Pharma, directing projects to support corporate strategy, clinical and preclinical R&D and Intellectual Property. Prior to joining Erytech Pharma, Dr. BLANC served as Corporate Strategic Intelligence Manager for SANOFI, in the Strategy Department, supporting Business Development and R&D. With dual-skills in Science & Business, Dr. BLANC holds a PhD in Life Sciences (U.K.) and a Master of Business in Biotechnology & Pharmaceutical Management ​(France).

  • Sébastien MARIE

    Clinical Operations Director

    15+ years of experience in clinical trial management. Prior to joining NEURONAX, he served as Clinical Project Manager for a mid-size CRO, managing various full-service national and international projects with biotech and big/mid-size pharma companies, from regulatory submissions to clinical study report writing. He recently participated in the development of drugs in rare diseases, managing several partners in Europe and in the US. Sébastien holds a Master Degree in biology, is specialized in clinical research and certified in international project management.